Pharvaris Sees Unusually-High Trading Volume - Heres Why - MarketBeat
| PHVS Stock | USD 18.74 0.58 3.00% |
Slightly above 62% of Pharvaris' investor base is looking to short. The analysis of the overall investor sentiment regarding Pharvaris BV suggests that many traders are alarmed. Pharvaris' investing sentiment can be driven by a variety of factors including economic data, Pharvaris' earnings reports, geopolitical events, and overall market trends.
Pharvaris |
Pharvaris Sees Unusually-High Trading Volume - Heres Why MarketBeat
Read at news.google.com
 |
Pharvaris Fundamental Analysis
We analyze Pharvaris' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Pharvaris is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Pharvaris BV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharvaris stock to make a market-neutral strategy. Peer analysis of Pharvaris could also be used in its relative valuation, which is a method of valuing Pharvaris by comparing valuation metrics with similar companies.
Peers
Pharvaris Related Equities
| HOWL | Werewolf Therapeutics | 5.88 | ||||
| RZLT | Rezolute | 3.74 | ||||
| TYRA | Tyra Biosciences | 2.78 | ||||
| IKNA | Ikena Oncology | 2.74 | ||||
| MOLN | Molecular Partners | 0.57 | ||||
| GLUE | Monte Rosa | 0.36 | ||||
| STOK | Stoke Therapeutics | 0.19 | ||||
| PEPG | PepGen | 0.51 | ||||
| ANTX | AN2 Therapeutics | 0.79 | ||||
| JANX | Janux Therapeutics | 1.08 | ||||
| PMVP | Pmv Pharmaceuticals | 1.44 | ||||
| MNOV | MediciNova | 2.07 | ||||
| ANEB | Anebulo Pharmaceuticals | 2.53 | ||||
| MLYS | Mineralys Therapeutics, | 2.83 | ||||
| DSGN | Design Therapeutics | 2.93 |
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.